drugset / Trial / NCT06188338

A 56-day Clinical Study on Facial Skin Rejuvenation

NCT06188338 ↗

Completed 24 enrolled Botanee Group Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical trial aims to learn about the efficacy of MLYAAT-1002® (a proprietary anti-aging complex, MLYAAT is short for "multi-layer anti-ageing technology" ) in female subjects who have newly received the rejuvenation treatment by comparing visual clinical scores, skin attributes measurement and image analysis.

Timeline

Start
2023-11-18
Primary completion
2024-01-27
Completion
2024-08-15

Drugs

EvaluationDrugModalityDoseRoute
Subject MLYAAT-1002® Unknown 1 unknown Topical

Indications